Comparison of Two Molecular Assays for Detection and Characterization of Aspergillus fumigatus Triazole Resistance and Cyp51A Mutations in Clinical Isolates and Primary Clinical Samples of Immunocompromised Patients

Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays

(2018) Hélène Guegan et al.   JOURNAL OF INFECTION

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study

(2017) Philipp Koehler et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis

(2017) A. F. A. D Schauwvlieghe et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs Directly from Plasma Samples

(2017) P. Lewis White et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit

(2017) Eric Dannaoui et al.   JOURNAL OF CLINICAL MICROBIOLOGY

FunResDB—A web resource for genotypic susceptibility testing of Aspergillus fumigatus

(2017) Michael Weber et al.   MEDICAL MYCOLOGY

Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis

(2016) J. Springer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study

(2016) T. Boch et al.   CLINICAL MICROBIOLOGY AND INFECTION

PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay ® in 201 patients with haematological disease suspected for invasive aspergillosis

(2016) G. M. Chong et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Human fungal pathogens: Why should we learn?

(2016) Jeong-Yoon Kim   JOURNAL OF MICROBIOLOGY

Clinical implications of globally emerging azole resistance inAspergillus fumigatus

(2016) Jacques F. Meis et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

(2015) Paul E. Verweij et al.   CLINICAL INFECTIOUS DISEASES

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

(2015) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

(2015) J. Steinmann et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs during Testing of Serum Samples

(2015) P. Lewis White et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative

(2015) P. Lewis White et al.   JOURNAL OF CLINICAL MICROBIOLOGY

High-Level Pan-Azole-Resistant Aspergillosis: TABLE 1

(2015) Jakko van Ingen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Validation of a New Aspergillus Real-Time PCR Assay for Direct Detection of Aspergillus and Azole Resistance of Aspergillus fumigatus on Bronchoalveolar Lavage Fluid

(2015) Ga-Lai M. Chong et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Update on Epidemiology of and Preventive Strategies for Invasive Fungal Infections in Cancer Patients

(2014) J. R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus—A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995–2013

(2014) Birgit Spiess et al.   PLoS One

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

(2013) C Orla Morrissey et al.   LANCET INFECTIOUS DISEASES

First Reported Case of Azole-Resistant Aspergillus fumigatus Due to the TR/L98H Mutation in Germany

(2012) P.-M. Rath et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of theAspergillus fumigatus cyp51AGene in Primary Clinical Samples from Neutropenic Patients

(2012) Birgit Spiess et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Hidden Killers: Human Fungal Infections

(2012) G. D. Brown et al.   Science Translational Medicine

Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)

(2011) M. Ruhnke et al.   ANNALS OF ONCOLOGY

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES